Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor

Molecular Vision

Volumn 14, Issue , 2008, Pages 556-561

  Kim, Jeong Hun ^a   Kim, Jin Hyoung ^a   Yu, Young Suk ^a   Jun, Hyoung Oh ^a   Kwon, Ho Jeong ^b   Park, Kyu Hyung ^c   Kim, Kyu Won ^a  

^a Seoul National University   (South Korea)

^b Yonsei University   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGIOGENESIS INHIBITOR; HOMOISOFLAVONE DERIVATIVE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; CELL ASSAY; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DRUG POTENCY; ENDOTHELIUM CELL; EYE TOXICITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LASER COAGULATION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TISSUE SECTION; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; ANIMALS; CAPILLARY PERMEABILITY; CELL MOVEMENT; CELL SURVIVAL; CHOROIDAL NEOVASCULARIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; HUMANS; ISOFLAVONES; LASER COAGULATION; MICE; MICE, INBRED C57BL; RETINA;

EID: 41549094525     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Folkman JAngiogenesisFJAnnu Rev Med200657118
2. AielloLPAveryRLAriggPGKeytBAJampelHDShahSTPasqua leLRThiemeHIwamotoMAParkJENguyen HVAiello LMFerrara N, King GLVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.N Engl J Med199433114807
3. Klein R, Wang Q, Klein BE, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995; 36:182-91.
4. Macular Photocoagulation Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trials. Arch Ophthalmol 1991; 109:1109-14.
5. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 2006; 38:450-71.
6. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinil neovascularization. Invest Ophthalmol Vis Sci 1986; 27:1644-52.
7. Shim JS, Kim JH, Lee J, Kim SN, Kwon HJ. Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata. Planta Med 2004; 70:171-3.
8. WAF1 expression. Biochem Biophys Res Commun. 2007In press
9. Min JK, Cho YL, Choi JH, Kim Y, Kim JH, Yu YS, Rho J, Mochizuki N, Kim YM, Oh GT, Kwon YG. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 2007; 109:1495-502.
10. Edelman JL, Castro MR. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res 2000; 71:523-33.